“We are the industrial area that invests the most in R&D, a productive and exporting engine”. larazon.es Developing and producing new medicines for society is both […]

The working group led by Farmaindustria holds a new meeting, with the participation of two new pharmaceutical companies. Farmaindustria.es The drive for clinical research in Primary […]

Of the €1.395 billion registered in 2022, 60% was devoted to clinical trial development. One out of every eight euros is already spent on basic and […]

Farmaindustria participates in the Medical Oncology, Haematology and Oncohaematology Pharmacy Congress ‘Building Bridges’, where data management in biomedical research was discussed. Farmaindustria.es “The proposed Regulation for […]

Farmaindustria’s CEO, Juan Yermo, participates in the conference ‘Towards a Comprehensive European Plan: Spain’s involvement with Rare Diseases’, organised by Feder in the Spanish Congress of […]

Farmaindustria presents the ‘Guide of good practice recommendations for the promotion of clinical research in Primary Care’, which will bring new treatment opportunities to patients in […]

The director of Farmaindustria’s Research Department participates in a round table on the regulation of this project held at the European Parliament Office in Madrid. “For […]

The Code of Conduct regulating the processing of personal data in clinical trials approved in 2022 makes it easier for companies and researchers to correctly comply […]

The director of Farmaindustria’s Access Department, Isabel Pineros, participates in the XVI International Congress on Rare Diseases: “In recent years we have seen great advances in […]

This is demonstrated by a recent study by Professor Frank R. Lichtenberg of Columbia University, which has just been published in the journal Value in Health. […]

On World Disease Day, which is celebrated on October 19, Farmaindustria remembers the importance of clinical trials, the previous step for the arrival of innovative treatments […]

The document proposes, without the need for a regulatory change, a procedure that would allow the equitable arrival of drugs that meet certain criteria that make […]

elglobal.es   In a political context with elections called for the European Parliament at the beginning of June 2024 and with Spain holding the presidency of […]

Between 2020 and 2022, 446 clinical trials with children and adolescents were conducted in our country, almost half of them focused on rare diseases and 90.4% […]

In recent years, the number of applications capable of interacting with patients to prevent, manage or treat diseases has increased, and which can also generate data […]

The 7th Congress of Patients’ Organisations, organised by the POP, analyses the application of the new European Regulation on Clinical Trials. Farmaindustria’s director general, Juan Yermo, […]

The vast majority of them are aimed at modifying the course of the disease, according to an Iqvia report on the future of R&D. In Spain […]

Only 7.5% are carried out in health centres. In order to alleviate this situation, Farmaindustria has presented a programme to promote them in outpatient clinics. Source: […]

“We are going to create a favourable environment”. This statement by José Manuel Miñones is the first step towards a roadmap that would highlight the key […]

“We must take advantage of the opportunity provided by the Spanish Presidency of the Council of the EU to include health, medicines and the innovative pharmaceutical […]

Over the next five years, the number of cancer treatments consisting of more than one drug will double, with 68 authorisations expected to be granted The […]

The forum, organised by the Menéndez Pelayo International University (UIMP) and Farmaindustria, will be held on 7 and 8 September in Santander Patient representatives, drug authorities, […]

The sector invests 41.5 billion euros in research and directly employs some 840,000 people 300 billion, exports ¤565 billion and contributes ¤175 billion to the EU-27 […]

Last year, the sector contributed 313 million euros for organisations and healthcare professionals to participate in research and development activities for new treatments For the eighth […]

One out of every three tests carried out in Europe takes place in Spain. Investment has grown by 5.3% annually since 2011, to almost 800 million […]

The associate director of Clinical and Translational Research at Farmaindustria, Amelia Martín Uranga, explained at a forum organised by the POP that work is already underway […]

On 23 May, part of the Distefar team attended the biomedical research technology platform. The opening was a conference by Juan José Vaquero, entitled “Strategy for […]